IHS Chemical Week

People & Business :: M&A

Moberg Pharma acquires three OTC brands in the US from Bayer HealthCare

4:40 AM MST | December 6, 2013 | Natasha Alperowicz

Moberg Pharma (Stockholm) announced today that it has signed a deal to acquire three well-established OTC brands in the United States from Bayer HealthCare for 32 million Swedish kronor ($4.8 million) in cash. Total annual sales for the brands are approximately SK20 million. The transaction is expected to close before the end of 2013.    The acquired portfolio includes Domeboro, a topical astringent used for relieving itch and minor skin irritations; Vanquish, an internal analgesic; and Fergon, an iron supplement. The brands will be sold through...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa